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Summary With certain concerns recently reported on metal-on-metal bearing couples in total
hip arthroplasty, this study’s objective is to review the current knowledge concerning release
of metal ions and its potential consequences. Each metal-on-metal implant presents different
tribological properties. The analytical techniques for metals are accurate and the Co ion rates
seem acceptable up to 2g/L. A delayed type IV hypersensitivity reaction (atypical lymphocytic
vasculitis-associated lesion [ALVAL]) may be the source of arthroplasty failure. Idiosyncratic, it
remains unpredictable even using cutaneous tests and apparently is rare (0.3%). Today, there
are no scientiﬁc or epidemiologic data supporting a risk of carcinogenesis or teratogenesis
related to the use of a metal-on-metal bearings couple. Solid pseudotumors nearly exclusively
are observed with resurfacing procedures, carrying a high annual revision rate in women under
40 years of age, occurring particularly in cases of acetabular malposition and with use of cast
molded Cr-Co alloys. Osteolysis manifests through complete and progressive radiolucent lines
or through cavitary lesions stemming from ALVAL-type alterations or impingement problems
or implant incompatibility. The formation of wear debris exceeding the biological tolerance is
possible with implant malposition, subluxation, and jamming of the femoral head in cases of
cup deformity. Moreover, each implant presents different metal ion production; assessment of
their performance and safety is required before their clinical use. With the knowledge available
today, metal-on-metal bearing couples are contraindicated in cases of metal allergies or end
stage renal dysfunction and sma
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Introduction
Since the 1990s, osteolysis, the disease related to wear
induced particle production, the diffusion of these particles
within the effective joint space deﬁned by Schmalzried et
al. [1], and the cytochemical consequences, has deﬁned the
longevity of total hip arthroplasty (THA). Second-generation
metal-on-metal couple implants were introduced in clinical
practice at the end of the 1980s by Weber [2], who pos-
tulated that the rate of THA loosening as a result of wear
induced osteolysis would be reduced [3]. Simulators now
show that standard 28- and 32-mm caliber metal-on-metal
bearing systems have lower volumetric wear than equivalent
polyethylene systems (PE). However, the particles gener-
ated by the metal-on-metal couples are smaller and their
number is 13,500 times higher (6—7× 1012 to 2—5× 1014 par-
ticles/year) than a metal-on-PE couple [4]. The metal wear
debris is produced in vivo by mechanical wear, corrosion,
and a combination of the two. These particles are small,
from ±10 to 120m (mean, 40m), perfectly soluble, and
the Co and Cr ions are bioactive.
In 1997, Brodner et al. [5] showed that the serum
and blood levels of circulating metal ions rose in patients
with metal-on-metal THA, particularly during the bedding-
in phase, which typically lasted 2 years. In the study by
Jacobs et al. [6], the circulating Co and Cr levels at 1 year
were increased six and 21 times respectively, compared
to the preoperative rates. Grübl presented the longest
follow-up (10 years) of a series of cementless THA with a 28-
mm MetasulTM metal-on-metal bearing (Zimmer, Winterthur,
Switzerland) —a Co-Cr alloy with a high concentration car-
bon (C)— and reported a mean serum concentration of
cobalt of 0.75g/L (range, 0.3—50g/L), for a threshold
normal value less than 1g/L. The interpretation of these
ﬁgures should take into consideration the complexity of tak-
ing these measurements. Each implant studied exhibited its
own tribologic characteristics, often not disclosed by the
manufacturer [8]. At worst, the diversity of the milieux
studied (blood, serum, urine) and the sampling and anal-
ysis methods used makes any comparison between the data
coming from different sources impossible.
Does the high Co-Cr rate have biological implications?
Plainly, yes and already in 2003, Jacobs et al. [6] wrote:
‘‘the biological implications of elevated metal levels in the
blood and urine remain the most signiﬁcant concern about
metal-on-metal couples’’ and they observed that there was
little knowledge about the toxicity threshold of degradation
products arising from Co-Cr alloy implants. In 2006, under
the auspices of the French Hip and Knee Society (Société
franc¸aise de la hanche et du genou [SFHG]), a review of
metal-on-metal bearing couples in hip arthroplasty vali-
dated the concept, but advised that long-term follow-up was
needed to clarify the incidence of loosening and osteolysis in
highly active patients [9]. Three years later, the objective of
this current study, once again at the initiative of the SFHG,
was to review the data available in the literature in 2009 on
metal-on-metal bearings, not only with conventional arthro-
plasties (with femoral stems) with standard 28- and 32-mm
heads —used since 1988— but also resurfacing procedures,
which were reintroduced in 1991, and more recent large-
diameter bearing couple systems (2003).
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iology and cobalt and chromium ion dosing
obalt and chromium belong to the periodic classiﬁcation
f elements and are near one another in the group of met-
ls. They are both prevalent in the environment and in food.
hey are indispensable to humans as trace elements in the
ody but are also toxic in higher concentrations. Popula-
ions studied include those who may have been exposed
o the metals, in particular, foundry workers in industry.
atients with Co-Cr metal-on-metal bearings are exposed to
ear with liberation of cobalt and chromium into the syn-
vial ﬂuid. These would migrate to the blood before being
xcreted in the urine.
ampling techniques
he ﬂuids monitored are serum, total blood, and urine.
xternal contamination must be prevented by the appro-
riate choice of sampling material and method. Blood is
ollected at the antecubital fossa with a tourniquet using
acutainer tubes. The main manufacturers of blood collec-
ion materials propose special trace element tubes contain-
ng an anticoagulant with a tube and cap that do not release
etals. The tubes can be transported at 4 ◦C and are stable
or approximately 2weeks with no alteration. A study con-
ucted by Goullé on roughly 30 elements (but not chromium)
howed that the cobalt concentration results revealed no
igniﬁcant variation if the blood was collected in Becton
ickinson classical glass tubes or special trace element tubes
n polyethylene terephthalate (PET) [10]. However, any
onitoring protocol should be carried out with special trace
lement tubes so as to standardize the collection conditions
nd adhere to the demands of quality assurance currently
equired of laboratories. For urine, a simple midstream sam-
le collected in a urine collection cup, transported at 4 ◦C
nd preserved for 1—2weeks, is appropriate.
obalt and chromium analysis techniques
here are two techniques: graphite furnace atomic
bsorption spectometry (AAS) and inductively coupled
lasma/mass spectrometer (ICP/MS).
In AAS, the sample to be analyzed is transformed into
tomic vapor in a graphite furnace heated to a high tem-
erature (2000 ◦C). This vapor, where atoms are found in
heir fundamental state, crosses a light beam whose length
s speciﬁc to the element to be analyzed, i.e., 283 nm for
hromium. This is chrome’s resonance line, which will allow
he atom to change to the ionized state by absorbing the
nergy of the light that crosses the vapor, thus reducing the
ntensity of the line, proportional to the number of ionized
toms, at the concentration of the elements to be tested in
he sample.
ICP/MS is a more powerful and high-performance tech-
ology than AAS, but at present, few laboratories have this
quipment. The principle is the following: the sample to
e analyzed is placed in a nebulization chamber contain-
ng a neutral gas —argon— and transformed into an aerosol
f very ﬁne droplets. The aerosol then passes through
n argon plasma subjected to a very high temperature
8000—10,000 ◦C) capable of dissociating, atomizing, and
896 C. Delaunay et al.
Table 1 Biological conversion factors.
Co 1g 17 nmol
1 nmol 0.06g
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onizing most elements. A differential vacuum system accel-
rates the plasma ions toward a collection of electrostatic
iscs that extract the positively charged ions and transport
hem toward a quadripole mass ﬁlter, which, depending on
he frequency applied to the quadripole, selects the ions
epending on their mass and charge. The ICP/MS provides
igh-performance analysis: rapid (1—2minutes compared to
ens of minutes with AAS) with high sensitivity. Cobalt’s
uantiﬁcation threshold, around 1g/L with AAS, reaches
.10g/L with ICP/MS. The cobalt and chromium results are
xpressed either in nanomoles (international units) or more
enerally in micrograms/liter. Cobalt’s molar mass is 58.8 g
59 g) and chromium’s is 51.9 g (52 g). This makes it possible
o deduce a conversion factor to switch from one unit to the
ther (Table 1).
eference values for blood and serum
lood and serum values are evaluated in the general pop-
lation, i.e., in individuals who are not exposed to these
lements. For chromium, the reference values in serum are
.50g/L according to the National Institute for Research
nd Safety (Institut national de recherche et sécurité [INRS])
nd are highly variable, with values from 1 to 35g/L in
hole blood reported by Lauwerys [11]. For cobalt, the usual
alue in serum and whole blood, respectively, is 0.4g/L
ccording to Lauwerys and 0.8g/L according to the INRS
12]. Red blood cell concentrations are more a reﬂection
f exposure over the last 3months and the life span of red
lood cells. In serum and whole blood, the reference values
n exposed populations, i.e., the guidance values in France
hat should not be exceeded, are very poorly documented.
nly the INRS provides a value guide for exposure to cobalt
n whole blood of 1g/L, which seems, according to Lauw-
rys [11], very stringent given the estimated concentration
f 0.8g/L in the general population.
The cobalt and chromium reference values in urine sam-
les are better deﬁned, as are many occupational medicine
xposure markers. According to the INRS, the urine concen-
rations found in non exposed people are less than 2g/g
f creatinine for cobalt and less than 0.5g/g of creati-
ine for chromium [13,14]. The value of surveillance through
rine sampling is to have available the limit values proposed
y the INRS: 15g/L post-shift and end of week for cobalt
nd 30g/g of creatinine post-shift and end of week for
hromium. However, the urine concentrations can only be
sed after having ruled out kidney failure.
eneral toxicology of cobalt and chromium
ons
he toxicology authorities, at least in France —although
oncerned— have poor knowledge of the systemic effects of
k
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rn atypical lymphocytic vasculitis-associated lesion: perivascu-
ar inﬁltrate of lymphocytes and accumulation of macrophages
ontaining metal particles (with permission, Ian Learmonth).
irculating Co and Cr produced by metal-on-metal arthro-
lasty bearing systems, although this cannot be ignored.
hey may impact on major biological and cellular functions
ith potential effects on the immune system, mutagenesis,
nd carcinogenesis.
otential immunological effects
n patients with metal-on-metal bearing THA, high levels
f circulating Co and Cr ions may be generated, and there
s a positive linear correlation with a lymphocytic reactiv-
ty, along with a signiﬁcant and dose-dependent reduction
f the T cell CD8 marker [15,16]. On the other hand, in
005, Willert et al. [17] described a surprising histological
eaction, observed in periprosthetic tissues sampled during
evisions of 19metal-on-metal THA presenting with unex-
lained pain and effusion. This histological entity includes
erivascular lymphocyte inﬁltration with accumulation of
lasma cells associated with macrophages containing par-
icles, and an increase in surface ulcerations (Fig. 1).
his highly speciﬁc reaction, called atypical lymphocytic
asculitis-associated lesion (ALVAL), may initiate an as yet
nknown metal-on-metal THA failure mode. Activation of
lymphocytes induces production of secreted cytokines,
hich results in accumulation of macrophages and an
ncrease in phagocyte activity and lytic enzyme concentra-
ions [18]. It is signiﬁcant that, whereas 14 of these THA
evised to non-metal-on-metal bearings were cured, the
ve who were revised with a new metal-on-metal bearing
ouple experienced persistent symptoms. This immunoal-
ergic histologic entity has also recently been reported in
emented acetabular explants that had undergone early
oosening (Nich et al., unpublished data).
The frequency of hypersensitivity reactions is not well
nown. For Engh et al., it was 0.3% for 1379UltametTM 36-
m THA (DePuy, Warsaw, IN, USA), with four revisions for
LVAL and a 7-year survival rate of 94.4% [19]. This 0.3% rate
s identical to the lead author’s personal series, with one
evision for femoral loosening caused by neck—cup impinge-
lasty
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ment and (histologically conﬁrmed) ALVAL in 340MetasulTM
28-mm THA, with a 99% 10-year survival rate.
Metal ions and chromosome aberrations
In the in vitro studies conducted by Daley et al. [20], the
wear debris artiﬁcially obtained from a simulator (caused
by overload, neck—cup impingement, or microseparation)
and added to ﬁbroblast cultures for 24 hours caused aneu-
ploidy (cell chromosome contents deviating from normal by
adding or subtracting chromosomes or chromosome pairs)
and translocation (exchange of segments between two chro-
mosomes). In the in vivo study by Ladon et al. [21], with
a highly sensitive detection threshold (ICP/MS at 0.2g/L
for Co, Cr, and Mo) and analysis at speciﬁc time points
over 2 years after metal-on-metal THA, the metallic wear
debris caused blood lymphocyte mutagenesis in a dose-
related manner. Moreover, the same team demonstrated
that the aneuploidy rate observed was three times greater
in the group of patients with metal-on-metal implants than
in a control group of patients with no prosthesis [22]. How-
ever, there could be considerable differences between the
metal wear particles obtained in vitro and in vivo. In serum,
the metal particles may be covered with protein deriva-
tives, identiﬁed as self and, therefore, not phagocytosed by
macrophages. Furthermore, identical and equally numerous
chromosome aberrations were detected in the whole blood
of patients with ceramic-on-ceramic couple implants, which
points toward an as yet unknown mechanism causing these
manifestations [23]. Be that as it may, the long-term clinical
implications of these anomalies remain poorly characterized
today, and enlightenment can only come through epidemio-
logical data provided by arthroplasty registries [24].
Teratogenic and carcinogenic risks
Metal ions can cross the placental barrier, but critical levels
vary depending on the bearing system studied and the sensi-
tivity of the analysis technique used. With a 28-mm Metasul
bearing with a high carbon concentration on a conventional
hip prosthesis (Alloclassic-CSF, Zimmer), placental passage
measured by AAS was low [25] but was more signiﬁcant ana-
lyzed by ICP/MS with a Birmingham Hip Replacement (BHR)
[26]. Nevertheless, the placental barrier seems partially
effective, since the ion rates found in cord blood in both
studies were nil or less than the rate found in the mother.
There have been no reports of teratogenicity in the litera-
ture to date, and current knowledge is based on speculation.
In 2007, the Medicine and Health Regulatory Agency (the
British equivalent of the French AFSSAPS) concluded that
there was no proof of any clinical expression of genotoxic-
ity induced by high levels of metal ions [24]. Nevertheless,
prospective studies are under way in Great Britain, compar-
ing the presence and progression of chromosome changes
in peripheral blood lymphocytes in young women of child-
bearing age who have a variety of resurfacing prostheses.Visuri et al. [27,28] have found no epidemiological evi-
dence of any carcinogenic risk caused by metal ions in the
Scandinavian registries. The persistence of a slight increase
in hemotological neoplasia is offset by a slightly reduced
incidence of other cancers.
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ocal toxicity of cobalt and chromium ions
he increase in the blood levels of metal ions, the descrip-
ion of delayed hypersensitivity reactions, as well as the
emonstration of pseudotumors have become almost obses-
ional topics. Has the concept of metal-on-metal bearings
enerated more fearsome complications than those encoun-
ered with other bearings?
seudotumors
n 2006, Boardman et al. [29] published a case of a solid
umor related to a resurfacing procedure. In 2008, Pandit
t al. [30] reported 20 cases of pseudotumors in different
ypes of resurfacing (BHR, Conserve Plus, Cormet) but only
ith female patients. These tumor lesions were not speciﬁc
o metal-on-metal couples since several publications exist
f cystic-type tumors occurring with metal-on-polyethylene
earings [31—35]. The clinical examination can identify a
alpable mass on the anterior or lateral surface of the hip
r even in the iliac fossa. Local erythema is possible and
nfection is occasionally suspected [36]. Pain can vary from
imple discomfort, a sensation of local tension, or it can be
igniﬁcant, leading to major functional handicap. Instability
subluxation, dislocation) has also been described, particu-
arly in cases of substantial joint effusion [37].
Pseudotumors can also be responsible for vascular
ompression syndromes with edema of the lower limb. But-
er and Barrack [38] reported two cases of iliac vessel
ompression due to a pelvic cystic mass occurring as a result
f polyethylene wear of the insert. Paralysis of the femoral
erve or lateral cutaneous nerve involvement in the thigh
ave also been described [39], Clayton et al. [40] reporting
ne case after resurfacing and Pandit et al. [30] three other
ases.
The imaging workup should include plain X-rays of the
elvis and hip, with measurement of cup inclination. Ultra-
ound identiﬁes whether the mass is solid or ﬂuid. The
T scan deﬁnes implant position, particularly anteroposte-
ior (version), and demonstrates the tumor location and its
xtension. MRI analyzes the tumor characteristics: cystic,
olid, or mixed.
ystic lesions
hirty-seven cases have been described, 34 of which for
etal-on-PE implants [31—35,37]. They can stem from
bnormal wear, loosening, or infection [31,36—38,41]. Wear
ebris (PE or metal) leads to an inﬂammatory reaction with
n increase in the volume of joint ﬂuid. The ﬂuid under
ressure can escape through the iliopsoas bursa if this com-
unicates with the joint or through a breach created by the
urgical approach [42].
olid or mixed lesionsoday, these lesions are for the most part associated
ith resurfacing [30]. Twenty-four such cases have been
escribed [29,30,40,43]. Symptoms appear early, at a mean
7months (range, 0—60months). They are located prefer-
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Other chromium-cobalt-molybdenum alloys have beenigure 2 Yellowish pseudotumor in contact with resurfacing:
ntraoperative view (with permission, Ian Learmonth).
ntially around the iliopsoas tendon and muscle and the
nterior part of the joint. The femoral nerve can be included
n the tumor. The surgical appearance matches that of
reyish-yellow tumors with cystic zones (Fig. 2). At times
issue necrosis is extensive, with destruction of muscles and
he adjacent nerves. Histology conﬁrms the extent of the
onnective tissue necrosis with cystic zones. Metal particles
wear debris) are found inside these pseudotumors. There
re perivascular lymphocyte aggregates and plasma cells.
ranulomatous reactions with giant cells have been found
round necrotic zones.
These tumor-like lesions may be related to an increase
n the volumetric production of wear debris caused by
mpingement or corrosion, galvanic or abrasive. There
s a size effect with ingestion of particles smaller than
50 nm regulated by endocytosis and pinocytosis [44].
articles larger than 150 nm can stimulate phagocytosis
y specialized cells such as macrophages. Inclusions of
etal particles have a cytotoxic effect on macrophages
nd also lead to a dose-dependent production of TNF
45,46,47]. This local overload of metal ions may, there-
ore, set off an inﬂammatory response mediated by the
mmune system. In addition, a type-IV delayed hypersen-
itivity such as that described by Willert et al. [17] could
e triggered by the local load of metal ions. When these
ytic enzymes are released by activated macrophages in
he surrounding tissue, localized tissue destruction can
esult.
The Oxford team reported an 8% incidence of these
symptomatic pseudotumors after resurfacing, with 15% of
hem in women [47]. Glyn-Jones et al. [48] indicated an
verall revision rate for inﬂammatory pseudotumors at 4%
25% for women less than 40 years of age). Grammatopoulos
t al. [49] reported a poor prognosis with these tumors, even
fter a complete change of the implant, with a complica-
ion rate of 50% (infection, recurrence, instability, paralysis
f the femoral nerve, loosening). Negative factors aris-
ng from review of these revisions include high circulating
etal rates, age less than 40 years, small implants, and
diagnosis of dysplasia, explaining the preponderance of
omen.
u
c
tC. Delaunay et al.
onventional metal-on-metal implants and
steolysis
steolysis related to metal-on-metal bearing implants is
arely mentioned in the literature and, when it is, the evalu-
tion criteria according to Zicat et al. [50,51] are not always
peciﬁed. The clinical and radiographic characteristics dif-
er from those of osteolysis from polyethylene resorption
ranulomas in the sense that functional and radiological
igns appear earlier [52—55].
How these lesions evolve varies depending on the etiology
metallosis from impingement, delayed hypersensitivity),
he type of acetabular implant ﬁxation, and the type of alloy
high or low carbon content, even the combination of the
wo). Osteolysis involves mainly the femoral side at Gruen
t al.’s zones I and VII [56] and exhibits a cavitary appear-
nce [52,54]. Acetabular osteolysis can also be cavitary in
e Lee and Charnley’s zone I [57]. Radiolucent lines mainly
nvolve the cup, reaching zones I, II, and III. At the femur,
he radiolucent lines are found in Gruen zones I, VI, VII, and
III.
Cemented acetabular ﬁxation directly into the bone
without using cage reinforcement) with a metal bearing
nsert has proved its non reliability. Lazennec et al. [53]
ound 31% radiolucent lines, 11% progressive, Nich et al. [55]
7% progressive, and Levai et al. [58] 15%. Lazennec et al.
53] described a 5% acetabular and 8% femoral rate of oste-
lysis. Long et al. [59] found only non evolving radiolucent
ines but at a high rate of 20%. However, the results of this
ype of implant reported by Girard et al. [60] proved to be
atisfactory at the medium term when they were cemented
n metallic supports (reinforcement cages).
The cementless implants with a MetasulTM insert have
emonstrated greater reliability. The osteolysis rate was
—1% for Delaunay et al. [61,62] and 3% for Beldame et
l. [52] (Fig. 3). Eswaramoorthy et al. [63] noted 5% non-
rogressive acetabular radiolucent lines at 10 years [62].
harma et al. [64] observed 18% stable acetabular radiolu-
ent lines and femoral radiolucent lines in 17% of cases with
mean of more than 7 years of follow-up. Long et al. [59]
oted 6% calcar resorption under the cementless femoral
tem collar and Migaud et al. [65] 80% calcar atrophy with
o osteolysis of cementless implants at more than 5 years of
ollow-up. Goetz et al. [66] believes this calcar resorption
oes not correspond to osteolysis. However, with a longer
ean follow-up of 92months, Holloway et al. [67] reported
ve cases of acetabular osteolysis with 22 cementless Meta-
ul FitekTM cups (Zimmer, Winterthur, Switzerland), with an
xcellent clinical result in active patients with a mean age of
9 years. The histological study in the only implant revised
or osteolysis could not implicate the involvement of metal
ebris, since no debris was found in the tissues examined.
he same was true in Carr and DeSteiger’s series [68], who,
ith the same implants, reported three revisions of Meta-
ul 28-mm bearings for proximal femoral osteolysis, a 2.6%
revalence after 3—9 years follow-up, with no loosening,
mpingement, or metallosis at revision.sed in bearing systems. These alloys differ in their carbon
ontents (high grade greater than 0.2% and low grade less
han 0.07%). They also differ in how they are manufactured
Metal ions and metal-on-metal bearings in total hip arthroplasty
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mer) hip resurfacing and 28-mm MetasulTM CLS/AlloﬁtTM THAFigure 3 Proximal osteolysis in zone 7, 5 years after implan-
tation of a hip prosthesis with hybrid ﬁxation.
(cast or wrought metal). With an UltimaTM insert with a high-
grade carbon and a low-grade S-ROM head, Park et al. [69]
described an early 5.9% osteolysis rate (24 at 41months):
the osteolysis was centered in the greater trochanter. With
the SikometTM bearing (ex-EndoPlus, Smith and Nephew,
Courbevoie, France) with a low carbon content, Milosev et
al. [54] found a 2.5% osteolysis rate with a mean follow-
up of 7 years; this was linear or extensive in zones I and
VII of the femur and zone I of the acetabulum. With the
same SikometTM implants, Korovessis et al. [70] observed 5%
femoral osteolysis, with 5—9 years of follow-up. With a high
carbon content LubrimetTM implant, at more than 10 years
of follow-up, Neumann et al. [71] observed 4% femoral oste-
olysis in zones I and VII, and 2% in zones II, VI, and VIII.
Since volumetric wear decreases with the increase in
carbon content, it seems preferable to use implants with
a high-grade metal-on-metal bearing couple. The size and
shape of the particles are not modiﬁed by the carbon content
and, therefore, do not explain the different reactions asso-
ciated with different metal-on-metal implant.
Osteolysis and resurfacing
The goal of resurfacing is optimal preservation of femoral
bone. In this type of implant, it is impossible to precisely
analyze the extent of femoral osteolysis. Only a progres-
sive decrease in the neck diameter can be evaluated. This
reduction was found in 2.8% of Conserve+ cases by Amstutz
(
C
t
C899
nd le Duff [72] and in 14.5% by Heilpern et al. [73] with
HR resurfacing. On the acetabular side, with the same
HR implant, Treacy et al. [74] did not mention osteoly-
is, whereas Steffen et al. [75] reported an 8.2% rate of
cetabular radiolucent lines.
esurfacing and large-diameter
etal-on-metal THA
he level of metal ions in the postoperative period is an indi-
ator of the performance of the bearing surfaces and also
llows ongoing surveillance of the implant, even if accept-
ble levels of Co and Cr ions have not yet been agreed
y the orthopaedic community. Be that as it may, the lev-
ls of metal ions in 28-mm MetasulTM bearings (Zimmer),
n use for more than 20 years, gave similar results to the
istorical McKee-Farrar prosthesis [7]. These Co ion levels
approximately 1 ug/L) should be considered the standard
n metal-on-metal hip replacement, and new developments
hould aim to reproduce them or reduce them further. The
aterial and design features of the implant that inﬂuence
etal-on-metal joint surface wear include: the diameter
f the bearing couple, the quality of the surface bearing,
he sphericity of the component, joint clearance, the man-
facturing process (forged metal versus cast metal), and
arbon content. The tribologic data show that, with equal
learance, a large-diameter component will create a thicker
iquid ﬁlm between the convexity of the femoral head and
he concavity of the acetabular component, thus minimizing
ear [76—78]. However, most of the data published on the
etal ion levels with large metal-on-metal bearings have
hown levels of Cr and Co ions at best similar to or higher
han those with 28-mm MetasulTM bearings [79,80].
Wear of joint surfaces is not the only source of metal
on release. It has been demonstrated that conical modu-
ar junctions also release a signiﬁcant amount of metal ions
hrough corrosion. This phenomenon is produced for all THA
odular implants and its magnitude can be related to the
umber and quality of the metal junctions [81]. In addition,
he metal surface of the implants can be the site of passive
orrosion in contact with organic ﬂuids, also generating ion
elease. This corrosion is produced when the protective ﬁlm
s damaged or interrupted by friction or micromovement,
eading to contact between the body ﬂuids and the metal
mplants.
Over the past few years, we have measured the con-
entrations of Cr, Co, and titanium (Ti) in patients with
MetasulTM 28-mm prosthesis, hip resurfacing (HR), and
n four types of large-head diameter, metal-on-metal THA
Fig. 4). Comparison of these different groups has made it
ossible to draw certain conclusions on the effects of dif-
erent characteristics of bearings and various implants.
8-mm implants and resurfacing
n a randomized controlled trial comparing DuromTM (Zim-Zimmer), we measured signiﬁcantly higher levels of Cr and
o at 3months in the hip resurfacing group compared to
he 28-mm THA group (2.0 versus 1.5g/L, p = 0.036 for
r, and 0.9 versus 0.7g/L, p = 0.035 for Co) [82]. How-
900 C. Delaunay et al.
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aigure 4 Zimmer systems for metal-on-metal bearing couple
uromTM, for arthroplasties with large-diameter heads (b), and
ver, at 24months postoperatively, no signiﬁcant difference
ersisted (1.6 versus 1.6g/L, p = 0.819 for Cr, and 0.7 ver-
us 0.9g/L, p = 0.207 for Co, for hip resurfacing and THA,
espectively). In the HR group, the concentration stabilized
t 1 year, after the bedding-in period, in comparison to the
8-mm THA group, in which the metal levels stabilized at
he end of the 3rdmonth. This study is reassuring because it
emonstrates that this large-diameter joint surface can pro-
uce, in vivo, Cr and Co ion rates comparable to the 28-mm
etasulTM standard. However, these results do not provide
ny conclusion about the effect of the couple diameter on
on production. Even though both groups in our study had
orged alloy implants (high-grade carbon Cr-Co-Mo with the
ame surface roughness and the same sphericity), they did
ot have identical joint clearance (≈ 45m for the 28-mm
HA versus ≈ 75m for the HR). The only means of deter-
ining whether couple size inﬂuences the level of metal
ons and wear would, therefore, be to evaluate a sufﬁ-
iently large cohort of hip resurfacing patients with ﬁxed
oint clearance, whatever the implant diameter.
It is noteworthy that for both groups (HR and 28-mm
HA), we observed higher mean concentrations of ions (Cr,
o, and Ti) in patients with acetabular components smaller
han 54mm and in women. Given that the diameter of the
earing is ﬁxed in 28-mm THA, the larger bearing diameter
n HR cannot be considered a favorable factor for reduc-
ng ions with the larger components. Similarly, the present
tudy showed a high level of Ti ions in 28-mm THAs and in
R (1.3 versus 1.9g/L at 24months, p = 0.001). Since Ti is
ot present on the bearing surfaces, its release results from
assive corrosion of the metal. A negative correlation was
oted between the component size and the Ti level. Since
arge-diameter implants have a potentially greater suscep-
ibility to corrosion, a positive correlation could have been
xpected. Sex may, therefore, be the main factor affecting
he metal ion levels (women have higher ion levels). The
ifference in ion levels between males and females may be
d
s
i
iorged Cr-Co with high carbon content: (a) 28-mm Metasul and
resurfacing version (c).
econdary to a variant in the metabolism of metal ions (dif-
erent lean mass, cellular or extracellular storage, or renal
xcretion). More in-depth research is undoubtedly neces-
ary to better understand the metabolism of metal ions.
ifferent pelvic morphology and gait may also contribute
o elevated ion levels in the female.
esurfacing and large-diameter THA
o quantify the portion of Cr and Co ions released by cor-
osion at the conical junction on the femoral neck and the
assive corrosion from the metal implant surface, we com-
ared the results of DuromTM (Zimmer) LDH-THA to those
sing the DuromTM HR system, which both have identi-
al bearing characteristics [83]. There was no difference
etween the two groups in terms of the patients or the
mplant sizes (p = 0.092 and 0.912). We detected mean Co
oncentrations that were 3.3 times higher in LDH-THA than
n HR (2.2 and 0.7g/L, p < 0.001).
Marked differences between HR and LDH-THA can be
ttributed to two main factors. The ﬁrst factor is that the
ested LDH-THA system incorporates an open femoral head
odel with head sizes 50mm and larger. The open femoral
ead model is associated with a 67% increase in ion release
3.0g/L for open heads versus 1.8g/L for closed heads;
= 0.037). A possible explanation is that the open femoral
ead model provides a larger surface contact for passive cor-
osion of the metal. This factor seems more important than
he theoretically favorable tribologic effect of the larger
iameter and the effect of sex (women were associated with
smaller bearing diameter and higher levels of metal ions).
The second factor, possibly responsible for the signiﬁcant
ifferences observed, relates to the fact that the LDH-THA
ystem used incorporates a Cr-Co sleeve adaptor for adjust-
ng the neck length (dual conical junction). To determine the
nﬂuence of adding this modularity, and to eliminate the bias
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introduced by the femoral head model (open versus closed),
we compared the femoral components with a diameter less
than 50mm in LDH-THA (closed femoral head models) and
HR. At 1 year of follow-up, the mean concentration of Co
was signiﬁcantly increased, by 157% for LDH-THA less than
50mm compared to HR less than 50mm (1.8 versus 0.7g/L,
p < 0.001). The main hypothesis to explain this difference is
the release of ions at the Cr-Co metal modular junctions
related to the addition of this sleeve adaptor.
Adding a dual conical adaptor as well as an open femoral
head model to LDH-THA was, therefore, a greater source of
metal ion release than joint surface wear. Industry, there-
fore, forfeited all the tribological advantage of a large
head in an attempt to reduce inventory. Furthermore, in
the LDH-THA, no signiﬁcant variation between 6-month
and 1-year follow-ups was noted in the metal ion concen-
trations, whereas with the HR, Co decreased signiﬁcantly
between 6months and 1 year (t-test for matched samples,
p = 0.0114). This suggests that even after having reached
steady state wear, the LDH-THA system continues to release
a large quantity of metal ions resulting from wear and pas-
sive corrosion at the conical junctions. Additional follow-up
is, therefore, needed to determine whether the maximum
levels are reached. These results raise considerable con-
cerns regarding the effects of adding modularity on metal
ion release and requires further research on LDH-THA.
Comparison of four types of large-diameter
THA
We compared 112 patients who had received one of the four
different brands of LDH-THA: Magnum/RecapTM (Biomet,
Warsaw, IN, USA), ASRTM (Depuy, Warsaw, IN, USA), Birm-
ingham Hip ReplacementTM (Smith & Nephew, Memphis, TN,
USA), and LDH DuromTM (Zimmer) with a prospective study
of the metal ion levels [84]. At 12months after implanta-
tion, the Co ion levels were similar except for the DuromTM
LDH, which exhibited a higher Co level. All the results were
higher than the concentrations of Co ions found at 12months
in the DuromTM HR (0.7g/L). Yet, all the LDH implants
present a Cr-Co conical modular adaptor for length adjust-
ment, except for the Magnum/Recap system whose adaptor
is made in Ti.
Interpretation of comparative studies
Other than bearing couple surface wear, passive corrosion of
the exposed metal surface is a factor inﬂuencing the metal
ion concentrations in the synovial ﬂuid and blood. When
interpreting and comparing the different implants, it is dif-
ﬁcult to establish exactly which proportion of the Cr and Co
metal ions come from passive corrosion of the joint surfaces,
the ﬁxation surface, the cone-shaped junction (in the THA),
and ﬁnally wear of the bearing couple surface. To estimate
the effect of passive corrosion in our studies, we decided to
measure Ti (a metal that is not part of the joint surfaces)
in our patients. We observed signiﬁcantly high levels of Ti in
all the study groups. Jacobs et al. [81] obtained very sim-
ilar results at 3 years after implantation, with a tripling of
Ti ions (4.13g/L) in a THA group with the Harris-Galante
IITM cup covered with porous Ti. In their 30-year follow-up
D
o
t
3
a901
f patients with a Ti THA, Dunstan et al. [85] reported a 50%
ncrease in Ti ion concentration.
In addition, corrosion and wear between two different
etals at the conical junctions is a known source of high
etal ions in the body. The phenomenon is present in all
odular hip implants, and its magnitude may be related to
he number and quality of these metal junctions. High con-
entrations of Ti ions could thus be directly proportional to
he metal surface exposed to passive corrosion. This is very
ifﬁcult to estimate, however, with plasma spray coating.
owever, the porous character of the treated zone signif-
cantly increases the surface exposed to Ti corrosion when
ompared to coatings whose surface was treated simply with
andblasting.
Taking into account the effects of metal corrosion on the
on level, it is probable that the differences between the
arious LDH-THA and HR systems results in part from metal
on sources other than those related to joint surface wear
tself, particularly when comparing components using differ-
nt ﬁxation methods (i.e., cemented or cementless femoral
omponents) and different surfaces for cementless ﬁxation
i.e., Cr-Co or plasma spray coating with Ti). For example, Cr
nd Co ion production from DuromTM HR is clearly less than
he ion data published from other brands such as the BHR
Smith & Nephew) and the Cormet 2000TM [83,84]. These
ther RH systems present a porous surface of the acetabu-
ar component in Cr-Co for secondary ﬁxation (which can be
considerable source of Cr-Co ions through passive corro-
ion) compared to the DuromTM system (which uses Ti plasma
pray coating for ﬁxation). However, it is difﬁcult to deter-
ine which situation is the best: a higher level of Cr-Co
hile avoiding Ti or a lower level of Cr-Co and Ti release.
ery little research has been done on the biological effects
f high Ti levels on the human body. The advantages of Ti
nclude a low elasticity modulus, very little immunogenic-
ty, and a high afﬁnity for ﬁxation through bone ingrowth
n the implant. Chronic occupational exposure to titanium
etrachloride can lead to its selective accumulation in the
ungs and adjacent lymph nodes and may be the cause of
ulmonary granulomatosis [86]. In his study comparing tis-
ue reactions to particles of Cr-Co, Ti, and polyethylene in
he failure of total knee arthroplasty (TKA), La Budde et
l. [87] observed that Ti was associated with a severe giant
ell reaction, whereas Cr-Co presented signiﬁcantly more
istiocytes per ﬁeld (101.5 versus 40.4; p = 0.002). They con-
luded that ‘‘this study demonstrates no difference in acute
r chronic inﬂammatory reaction between the two alloys’’.
i acetabular and femoral implants have been used very
uccessfully in THA for decades. As shown by our earlier
tudy, the CLS/Alloﬁt THA releases a large quantity of Ti,
ven 2 years after implantation (1.30g/L at 2 years versus
.57g/L preoperatively). Yet, this type of femoral stem
nd other similar stems have been implanted in large num-
ers throughout the world over the past 25 years. The level
f Ti in our HR cases at 2 years was 1.87g/L, corresponding
o 1.4 times the level with cementless THA.
Moreover, even though the ion levels reported with
uromTM LDH-THA are higher than those with HR and
ther LDH systems tested, they remain comparable to
he concentrations measured after TKA (Cr, 0.92g/L; Co,
.28g/L), after spinal column surgery (Cr, 1.0—10.5g/L
nd Ti, 2.6g/L), or after intramedullary nailing of the tibia
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88—91]. It is surprising to observe that little mention was
ade of the potentially adverse effects of metal ions in
rthopaedic domains other than hip arthroplasty, where,
or example, young women who have undergone vertebral
rthrodesis to correct scoliosis continue to carry their metal-
ic instrumentation during pregnancy and breastfeeding.
onclusions
sing appropriate methodology for trace element analysis,
ssessment of cobalt and chromium is sensitive, accurate
nd reproducible.
The rate of circulating Co and Cr ions is low when the
earing couple functions well (Co < 1g/L).
Hypersensitivity is idiosyncratic, unpredictable with
utaneous tests, speciﬁc to metal-on-metal couples, and
pparently rare: 0.3%.
Metal-on-metal bearing couple surfaces allow the sur-
eon to increase the size of the femoral head in THA. This is
dvantageous from a number of points of view, in particular
or joint stability and to prevent component impingement.
owever, this new technology has been associated with new
roblems. In addition to joint surface wear, passive corrosion
f metallic surfaces exposed to biological ﬂuids is a factor
nﬂuencing ion concentrations. When evaluating metal ion
elease arising from metal-on-metal THA, one should con-
ider the total load of metal coming not only from bearing
ear but also from metallic junctions wear and implant cor-
osion. Each implant using metal-on-metal bearings has its
wn characteristics; assessment of their performance and
afety is required before they are widely used.
Metal-on-metal implants do not tolerate any malposition.
imilarly, female sex seems to be signiﬁcantly associated
ith higher circulating metal ions, undoubtedly related
o the use of smaller components. Patients with a long
ife expectancy with high ion values have a greater long-
erm risk of undesirable side effects than those with
ormal levels. Identiﬁcation of the factors that adversely
ffect the bearing should remain a research priority and
equires collaboration between clinicians, epidemiologists,
nd industry.
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